Advertisement
Notícias Forex
Japan Data On Tap For Thursday
Japan is scheduled to release a raft of data on Thursday, highlighting a busy day for Asia-Pacific economic activity. On tap are October numbers for industrial production, retail sales, construction orders and housing starts, as well as November results for its consumer confidence index.
RTTNews |
561 dias atrás
U.S. Dollar Showing Modest Move Back To The Upside
After trending lower over the past few days, the value of the U.S. dollar has moved modestly higher over the course of trading on Wednesday.
RTTNews
|
561 dias atrás
Euro Weakens As German Inflation Eases More Than Expected
The euro fell against its major counterparts in the New York session on Wednesday, as German inflation eased in November to the lowest level in nearly two-and-a-half years.
RTTNews
|
561 dias atrás
Canadian Market Modestly Higher At Noon
The Canadian market is turning in a mixed performance on Wednesday. While optimism about the outlook for interest rates contribute a bit to market's rise, growth worries and caution ahead of some crucial U.S. and Canadian economic data appear to be limiting the upside.
RTTNews
|
561 dias atrás
U.S. Dollar Erases Losses Against Majors
The U.S. dollar rose against its most major counterparts in the European session on Wednesday, after falling in the previous session on the back of dovish remarks from Fed Governor Christopher Waller.
RTTNews
|
561 dias atrás
AbbVie Announces Topline Results From Phase 2 LUMINOSITY Trial Of Telisotuzumab-Vedotin
Biopharmaceutical company AbbVie, Inc. (ABBV) announced Wednesday topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC). The trial demonstrated compelling clinical benefits across key endpoints.
RTTNews
|
561 dias atrás
Philips' Stock Hit By FDA Warning Against DreamStation 2 CPAP Machines
Shares of Philips Electronics NV were losing around 5 percent in Amsterdam trading as well as in the pre-market activity on the NYSE after the U.S. regulator warned against the safety of Dutch consumer electronics giant's DreamStation 2 Continuous Positive Airway Pressure or CPAP Machines. The Food and Drug Administration or FDA said it is alerting patients and healthcare providers of an emerging
RTTNews
|
561 dias atrás
more news
Pasithea Announces Receipt Of FDA Response Of Pre-IND Meeting For PAS-004 Clinical Development
Biotechnology company Pasithea Therapeutics Corp. (KTTA) announced Wednesday receipt of written responses to questions submitted for a Type 2 pre-Investigational New Drug Application (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding clinical development plan for PAS-004.
RTTNews
|
561 dias atrás
UniQure Says FDA Clears IND Application For AMT-191 Gene Therapy For Fabry Disease
Gene therapy company uniQure N.V. (QURE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for AMT-191, the Company's gene therapy candidate for Fabry disease.
RTTNews
|
561 dias atrás
U.S. GDP Jumps More Than Previously Estimated In Q3
Revised data released by the Commerce Department on Wednesday showed the U.S. economy grew faster than previously estimated in the third quarter of 2023. The Commerce Department said the jump by real gross domestic product in the third quarter was upwardly revised to 5.2 percent from the previously reported 4.9 percent.
RTTNews
|
561 dias atrás
UK Mortgage Approvals Hit 3-Month High
UK mortgage approvals increased more than expected to a three-month high in October signaling a slowdown in the housing market downturn after the central bank kept interest rates unchanged in September and November. Net mortgage approvals for house purchases rose to a three-month high of 47,400 in October from 43,700 in September, the Bank of England reported Wednesday.
RTTNews
|
561 dias atrás
Okta Boosts FY24 Outlook As Q3 Results Top Estimates
Independent identity partner Okta, Inc. (OKTA) reported Wednesday a net loss for the third quarter of $81 million or $0.49 per share, sharply narrower than $209 million or $1.32 per share in the prior-year quarter.
RTTNews
|
561 dias atrás
Bay Street Likely To Open On Positive Note
Canadian shares are likely to open higher on Wednesday, tracking positive European stocks, and higher crude oil prices. Optimism about interest rate cuts from the first quarter of 2024 is also likely to support the market.
RTTNews
|
561 dias atrás
Stay up to date!
Add Notícias to your browser
Add To Chrome
